...
首页> 外文期刊>Reviews in Endocrine and Metabolic Disorders >Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients
【24h】

Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients

机译:内分泌干​​扰物(EDC)和女性癌症:告知患者

获取原文
获取原文并翻译 | 示例
           

摘要

Breast and uterine cancer are the most frequent female gender related neoplasms whose growth is mostly estrogen dependent. Therefore, any EDC exhibiting estrogenic effects may increase the risk of these two malignancies. This review focuses on the potential role of EDCs with estrogenic potential on the risk of breast and uterine neoplasms but also points to the possible role of the exposure to EDCs in the pathogenesis of ovarian and cervical cancer. It also underlines the necessity of informing the public about the presence of EDCs in common consumer products, their detrimental health effects and methods of reducing the exposure risk.
机译:乳腺癌和子宫癌是最常见的与女性性别相关的肿瘤,其生长主要取决于雌激素。因此,任何表现出雌激素作用的EDC都可能增加这两种恶性肿瘤的风险。这项审查侧重于具有雌激素潜能的EDC对乳腺癌和子宫肿瘤风险的潜在作用,但同时也指出了暴露于EDC在卵巢癌和宫颈癌发病机理中的可能作用。它还强调有必要向公众通报普通消费品中EDC的存在,其有害的健康影响以及降低接触风险的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号